Outpatient, with close follow-up for exposed persons that includes: 
Counseling
Baseline and follow-up<unk>  testing
Monitoring for drug toxicity
Follow-up appointments should begin within 72 hours of an<unk><unk> 
Counseling
Baseline and follow-up<unk>  testing
Monitoring for drug toxicity
Follow-up appointments should begin within 72 hours of an<unk><unk>
HIV post-exposure prophylaxis
Ritonavir-boosted nirmatrelvir
COVID-19 Vaccine 
Ritonavir
Molnupiravir
Abacavir/lamivudine
Isolation precautions
Emtricitabine/tenofovir